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INTRODUCTION
Epithelioid hemangioendothelioma is a rare vascular tumor
that usually develops in the lung, liver, bone, and soft tissue,
and has a prognosis varying from benign to malignant. Hep-
atic epithelioid hemangioendothelioma usually occurs in adult
women and presents as multiple masses, and its confirmatory
diagnosis is made by biopsy (1). Several cases have been report-
ed in Korean literature, too (2).
On the other hand, hypertrophic osteoarthropathy is a syn-
drome characterized by periosteal new bone formation, club-
bing and joint effusion. It develops as a primary disease or
secondary to chronic pulmonary disease, cyanotic heart disease,
inflammatory bowel disease, or chronic liver disease (3). We
recently experienced a rare case of hypertrophic osteoarthropa-
thy which developed in association with epithelioid heman-
gioendothelioma.
CASE REPORT
A 42-yr-old man visited our rheumatology clinic because
of bilateral ankle arthritis in May 2002. He was diagnosed as
having chronic hepatitis B in 1992, and multiple liver masses
were found incidentally in July 1996. A liver biopsy performed
at the time revealed prominent epithelioid cells containing
the factor VIII-related antigen. These findings were consis-
tent with epithelioid hemangioendothelioma in the liver. He
received conservative management. He had no musculoskele-
tal complaints or abnormal physical findings at that time.
Pleural effusion and several lung masses developed in the
right lung in July 2000. Biopsy findings of the pleural mass
showed dysplastic epithelioid hemangioendothelioma with
pleomorphisms, mitoses, and necrosis. It was speculated that
the liver masses had metastasized to the right lung and the
pleura. In April 2002, he began to feel pain and swelling in
both ankle joints, which then extended to both wrists and
knees. He visited our clinic because of this increasing pain
and swelling of affected joints. Physical examination revealed
swelling and tenderness of both ankle and wrist joints and
mild tenderness of the right knee joint. Pitting edema was
found in both lower legs, and prominent clubbing was found
in all fingers of both hands. Laboratory data showed hemo-
globin 13.6 g/dL, white blood cell count 5,700/ L, platelet
count 182,000/ L, erythrocyte sedimentation rate 35 mm/hr
(reference range, 0-10 mm/hr), alkaline phosphatase 180 IU/L
(reference range, 30-115 IU/L), AST/ALT 35/38 IU/L (refer-
ence range, 0-40 IU/L, 0-40 IU/L, respectively), negative
rheumatoid factor, and negative antinuclear antibody. Bone
scan showed diffuse cortical uptake in the distal parts of both
femurs and tibias (Fig. 1), and plain radiography showed sub-
periosteal new bone formation in the same areas (Fig. 2). Imm-
unohistochemistry staining of the tumor tissue showed the
presence of vascular endothelial growth factor (VEGF) (Fig.
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A Case of Hypertrophic Osteoarthropathy Associated with Epithelioid
Hemangioendothelioma 
Epithelioid hemangioendothelioma is a rare vascular tumor, which occurs in the lung,
liver, bone, and soft tissue. Hypertrophic osteoarthropathy is a syndrome character-
ized by subperiosteal new bone formation, joint effusion and clubbing, and may be
associated with cyanotic heart disease, chronic pulmonary disease, liver disease,
and other miscellaneous diseases. The activation of endothelium and platelets has
been suggested to be involved in the development of hypertrophic osteoarthropathy.
We report a rare case of hypertrophic osteoarthropathy, which developed in asso-
ciation with hepatic epithelioid hemangioendothelioma with pulmonary metastasis.
We also discuss the role of vascular endothelial growth factor in its pathogenesis.
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3). A diagnosis of hypertrophic osteoarthropathy was made,
and naproxen was prescribed, which relieved the arthritis and
swelling in both lower legs. However, he was readmitted
because of radiation-resistant metastatic lung lesions in April
2002 and was discharged hopelessly.
DISCUSSION
A diagnosis of epithelioid hemangioendothelioma was made
on our patient, based on the typical biopsy findings of the
dysplastic proliferation of factor VIII-related antigen positive
cells. Epithelioid hemangioendothelioma was first reported
by Dail and Liebow in 1975 as an intravascular sclerosing
bronchoalveolar tumor of the lung. In the following studies,
features of endothelial cells were observed in round or cuboid
tumor cells on electron microscopy (Weibel-Palade body) and
on immunohistochemistry (factor VIII-related antigen, von
Willebrand factor). These findings suggest that epithelioid
hemangioendothelioma originate from endothelial progenitor
cells (4).
The case described in this report was diagnosed as hyper-
trophic osteoarthropathy based on findings of clubbed fingers,
arthritis, and periosteal reactions, which were confirmed by
typical radiographic and bone scan findings. His arthralgia
responded very well to nonsteroidal anti-inflammatory drugs.
Fig. 1. Bone scan sh-
owing symmetric, dif-
fuse cortical uptake
around the diaphysis
in both tibias and fe-
murs. The uptake of
the right ribs is attribut-
ed to tumor invasion.
Fig. 2. Plain radiograph
of femur showing peri-
osteal reaction on the
medial and lateral as-
pects (arrow heads).
Fig. 3. Specimen from a lung biopsy. (A) Pleomorphic polygonal cells with intracellular vascular lumina containing red blood cells (H&E,
×400). (B) Tumor cells are strongly immunostained (brown color) with antibody to vascular endothelial growth factor (Hematoxylin basal
stain, ×400).
A B486 J.H. Kim, E.B. Lee, S. Kim, et al.
The pathologic findings of hypertrophic osteoarthropathy are
known to show vascular hyperplasia and activated endothelial
cells in clubbed fingers, and vascular hyperplasia and perios-
teal proliferation in affected bones. In cases of cyanotic heart
disease, the activation of cytokine-producing endothelial cells
by macrothrombocytes is found, which might be a mechanism
of hypertrophic osteoathropathy (5). Plasma levels of the von
Willebrand factor antigen, which is a marker of endothelial
cells, is known to be elevated in hypertrophic osteoarthropa-
thy (6). These findings suggest that the activation of endothe-
lial cells and platelets plays an important role in the patho-
genesis of hypertrophic osteoarthropathy. Recently, the plas-
ma and serum levels of VEGF, a hypoxia-inducible cytokine
secreted by various cells including platelets, were found to
be increased in patients with hypertrophic osteoarthropathy.
The ability of VEGF to promote angiogenesis and the differ-
entiation of osteoblasts (3, 8) suggests a role of VEGF in the
development of hypertrophic osteoarthropathy. 
The endothelial origin of epithelioid hemangioendothelioma
suggests a link between the tumor and hypertrophic osteoar-
thropathy. Recently several reports have suggested an associa-
tion between epithelioid hemangioendothelioma and VEGF.
VEGF and VEGF receptors were found in a child case of
epithelioid hemangioendothelioma (9), and VEGF blood
levels were found to be reduced after tumor treatment with
interferon- (10). These findings suggest that VEGF play an
important role in the pathogenesis of epithelioid hemangioen-
dothelioma and hypertrophic osteoarthropathy in our patient.
Consistent with this hypothesis, we observed the presence of
VEGF in the tumor tissue of our patient (Fig. 3).
To the best of our knowledge, two case reports of epithelioid
hemagioendothelioma complicated by hypertrophic osteoar-
thropathy have been reported. In one report, hypertropic
osteoarthropathy was found in a 17-yr-old boy, concurrently
with hepatic and pulmonary epithelioid hemangioendothe-
lioma (11). In the other, hypertrophic osteoarthropathy was
diagnosed in a 24-yr-old woman concurrently with pulmonary
epithelioid hemangioendothelioma (12). Our case is the first
Korean case of hypertrophic osteoarthropathy developing in
the presence of epithelioid hemangioendothelioma. This case
differs from previous reports in that the tumor was first found
in the liver and hypertrophic osteoarthropathy developed after
pulmonary metastasis, thus emphasizing the implication of
a tumor in the lung in the pathogenesis of hypertrophic os-
teoarthropathy. Furthermore, our case suggests that heman-
gioendothelioma, albeit rare, should be included in the dif-
ferential diagnosis of hypertrophic osteoarthropathy. 
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